Stock IMC IMMURON LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Immuron Limited

Equities

IMC

AU000000IMC7

Pharmaceuticals

Market Closed - Australian S.E.
Other stock markets
 02:10:44 2024-04-26 am EDT 		5-day change 1st Jan Change
0.105 AUD 0.00% Intraday chart for Immuron Limited +5.00% +36.36%
Apr. 10 Immuron Limited Provides Sales Results for the Quarter and Year to Date Ended March 2024 CI
Apr. 10 Immuron's Global Sales Climb 51% in March Quarter; Shares Surge 18% MT

Business Summary

Immuron Limited is an Australia-based biopharmaceutical company focused on developing and commercializing orally delivered targeted polyclonal antibodies for the treatment of infectious diseases. It operates through two segments: Research and development (R&D), and Hyperimmune products. The R&D segment is focused on R&D projects in Australia, Israel and the United States. The Company's flagship commercial products consist of Travelan and Protectyn. Travelan is an over the counter orally administered passive immunotherapeutic product indicated to reduce the risk of travelers' diarrhea, reduce the risk of minor gastro-intestinal disorders and is antimicrobial. Protectyn is sold online and in health practitioner clinics and is marketed as an immune supplement to help maintain a healthy digestive function and liver. The Company has four clinical programs -Travelan (IMM-124E), CampETEC, IMM-529 and Travelan (consumer product).

Sales per Business

AUD in Million2022Weight2023Weight Delta
Hyperimmune Products
100.0 %
1 100.0 % 2 100.0 % +135.85%

Sales per region

AUD in Million2022Weight2023Weight Delta
Australia
64.3 %
0 26.2 % 1 64.3 % +478.05%
United States
35.6 %
1 65.5 % 1 35.6 % +28.25%
Canada
0.1 %
0 8.3 % 0 0.1 % -98.10%

Managers

Managers TitleAgeSince
Steven Lydeamore CEO
 Chief Executive Officer 56 22-06-26
Phillip Hains DFI
 Director of Finance/CFO 64 13-04-18
Joanne Casey CTO
 Chief Tech/Sci/R&D Officer 47 -
Jerry Kanellos COO
 Chief Operating Officer 61 15-06-30
Flavio Palumbo PRN
 Corporate Officer/Principal 50 22-10-31
Travis Robins PRN
 Corporate Officer/Principal - -
Reza Moussakhani PRN
 Corporate Officer/Principal - 13-08-31

Members of the board

Members of the board TitleAgeSince
Roger Aston BRD
 Director/Board Member 68 12-03-19
Daniel Pollock BRD
 Director/Board Member 64 12-10-10
Stephen Anastasiou BRD
 Director/Board Member 67 13-05-27
Paul Brennan CHM
 Chairman 63 22-03-15
Ravi Savarirayan BRD
 Director/Board Member 57 17-04-06

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 227,798,346 186,838,122 ( 82.02 %) 0 82.02 %

Shareholders

NameEquities%Valuation
Grandlodge Capital Pty Ltd.
2.273 %
5,178,899 2.273 % 388 573 $
Stephen Anastasiou
2.143 %
4,882,388 2.143 % 366 326 $
Russell Kay Hancock
1.317 %
3,000,000 1.317 % 225 090 $
Karma Wealth Pty Ltd.
1.120 %
2,551,665 1.120 % 191 451 $
Texas Woods Pty Ltd.
1.016 %
2,314,674 1.016 % 173 670 $
Gravcon Pty Ltd.
0.8780 %
2,000,000 0.8780 % 150 060 $
Insync Investments Pty Ltd.
0.8780 %
2,000,000 0.8780 % 150 060 $
Roger Aston
0.6674 %
1,520,376 0.6674 % 114 074 $
William David Frank Bird
0.6585 %
1,500,000 0.6585 % 112 545 $
Hallam Drainage Pty Ltd.
0.6497 %
1,480,064 0.6497 % 111 049 $
NameEquities%Valuation
Morgan Stanley Capital Services LLC
0.0683 %
3,891 0.0683 % 10 233 $
BNP Paribas Arbitrage SA
0.0281 %
1,600 0.0281 % 4 208 $
Stephens Consulting LLC
0.0263 %
1,500 0.0263 % 3 945 $
Global Wealth Management Investment Advisory, Inc.
0.001756 %
100 0.001756 % 263 $

Company contact information

Immuron Ltd.

62 Lygon Street Level 3

3053, Carlton

+61 3 9824 5254

http://www.immuron.com
address Immuron Limited(IMC)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Biopharmaceuticals

Sales per Business

Sales per region

Sector Biopharmaceuticals

1st Jan change Capi.
IMMURON LIMITED Stock Immuron Limited
+36.36% 15.61M
CSL LIMITED Stock CSL Limited
-4.66% 86.13B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
+1.32% 39.82B
BIOGEN INC. Stock Biogen Inc.
-19.27% 30.42B
UCB Stock UCB
+57.86% 25.23B
INCYTE CORPORATION Stock Incyte Corporation
-17.69% 11.6B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. Stock Chongqing Zhifei Biological Products Co., Ltd.
-43.00% 11.51B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. Stock Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
-9.14% 11.95B
SWEDISH ORPHAN BIOVITRUM AB Stock Swedish Orphan Biovitrum AB
+5.24% 8.71B
INNOVENT BIOLOGICS, INC. Stock Innovent Biologics, Inc.
-8.42% 8.12B
Biopharmaceuticals
  1. Stock Market
  2. Equities
  3. IMC Stock
  4. Company Immuron Limited